David Westenberg
Stock Analyst at Piper Sandler
(4.71)
# 158
Out of 5,124 analysts
188
Total ratings
61.68%
Success rate
27.29%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Overweight | $150 | $81.84 | +83.28% | 1 | Dec 1, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $15 → $19 | $16.31 | +16.49% | 3 | Nov 11, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $105 → $80 | $59.05 | +35.48% | 6 | Nov 11, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Neutral | $1.5 → $2 | $1.87 | +6.95% | 10 | Nov 11, 2025 | |
| NTRA Natera | Maintains: Overweight | $220 → $230 | $229.09 | +0.40% | 17 | Nov 11, 2025 | |
| FLGT Fulgent Genetics | Maintains: Neutral | $21 → $30 | $26.27 | +14.20% | 10 | Nov 11, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $70 → $80 | $101.56 | -21.23% | 13 | Nov 11, 2025 | |
| CTKB Cytek Biosciences | Maintains: Overweight | $8 → $7.5 | $5.05 | +48.51% | 10 | Nov 11, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $200 | $173.53 | +15.25% | 8 | Oct 27, 2025 | |
| GH Guardant Health | Maintains: Overweight | $60 → $90 | $102.14 | -11.89% | 10 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 → $6.5 | $6.99 | -7.01% | 13 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $16.24 | +23.15% | 15 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $140 | $130.06 | +7.64% | 3 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $215 | $125.82 | +70.88% | 15 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $510 → $700 | $676.53 | +3.47% | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $18 | $22.63 | -20.46% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $11 | $11.76 | -6.46% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $185 | $131.16 | +41.05% | 16 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $260 → $280 | $250.88 | +11.61% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $28.56 | - | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $37.37 | - | 1 | Nov 21, 2017 |
BillionToOne
Dec 1, 2025
Initiates: Overweight
Price Target: $150
Current: $81.84
Upside: +83.28%
10x Genomics
Nov 11, 2025
Maintains: Neutral
Price Target: $15 → $19
Current: $16.31
Upside: +16.49%
Tempus AI
Nov 11, 2025
Maintains: Neutral
Price Target: $105 → $80
Current: $59.05
Upside: +35.48%
Pacific Biosciences of California
Nov 11, 2025
Maintains: Neutral
Price Target: $1.5 → $2
Current: $1.87
Upside: +6.95%
Natera
Nov 11, 2025
Maintains: Overweight
Price Target: $220 → $230
Current: $229.09
Upside: +0.40%
Fulgent Genetics
Nov 11, 2025
Maintains: Neutral
Price Target: $21 → $30
Current: $26.27
Upside: +14.20%
Exact Sciences
Nov 11, 2025
Maintains: Overweight
Price Target: $70 → $80
Current: $101.56
Upside: -21.23%
Cytek Biosciences
Nov 11, 2025
Maintains: Overweight
Price Target: $8 → $7.5
Current: $5.05
Upside: +48.51%
Quest Diagnostics
Oct 27, 2025
Maintains: Neutral
Price Target: $190 → $200
Current: $173.53
Upside: +15.25%
Guardant Health
Oct 22, 2025
Maintains: Overweight
Price Target: $60 → $90
Current: $102.14
Upside: -11.89%
Oct 16, 2025
Reiterates: Neutral
Price Target: $5 → $6.5
Current: $6.99
Upside: -7.01%
Oct 15, 2025
Maintains: Overweight
Price Target: $15 → $20
Current: $16.24
Upside: +23.15%
Sep 11, 2025
Maintains: Overweight
Price Target: $120 → $140
Current: $130.06
Upside: +7.64%
Aug 11, 2025
Maintains: Overweight
Price Target: $210 → $215
Current: $125.82
Upside: +70.88%
Aug 11, 2025
Maintains: Neutral
Price Target: $510 → $700
Current: $676.53
Upside: +3.47%
Aug 11, 2025
Maintains: Neutral
Price Target: $12 → $18
Current: $22.63
Upside: -20.46%
Aug 4, 2025
Maintains: Overweight
Price Target: $12 → $11
Current: $11.76
Upside: -6.46%
May 15, 2025
Maintains: Overweight
Price Target: $190 → $185
Current: $131.16
Upside: +41.05%
May 6, 2025
Maintains: Neutral
Price Target: $260 → $280
Current: $250.88
Upside: +11.61%
Jan 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $28.56
Upside: -
Nov 21, 2017
Initiates: Neutral
Price Target: n/a
Current: $37.37
Upside: -